PACTR201206000391313招募中未知
The pharmacokinetics of lopinavir/ritonavir, nevirapine and efavirenz when given with isoniazid in South African HIV-infected individuals
niversity of Cape Town0 个研究点目标入组 70 人开始时间: 2012年6月14日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Year(s) 至 100 Year(s)（—）
- 性别
- All
入选标准
- •Stable on ART: efavirenz, nevirapine or lopinavir/ritonavir
排除标准
- •Using CYP450 inducers/inhibitors
- •Excessive alchol use
- •Intolerant to isoniazid
研究者
相似试验
招募中
3 期
Comparing the effectiveness of Kaletra/Hydroxychloroquine and Atazanavir/Dolutegravir/Hydroxychloroquine treatment regiments in COVID-19 treatmentCOVID-19.covid-19 virus identifiedU07.1IRCT20210214050350N1Iran University of Medical Sciences60
招募中
不适用
The pharmacokinetics of lopinavir in South African HIV-infected volunteers receiving rifampicin with adjusted doses of LOPINAVIR/ritonavir.TuberculosisPACTR201206000159453CT
已完成
1 期
Pharmacokinetics of Lopinavir/Ritonavir at Three Different Doses.Acquired Immunodeficiency SyndromeNCT00985543Kirby Institute22
终止
4 期
Pharmacokinetic Study of Two HIV Protease Inhibitors in PatientsHIV InfectionNCT00420355University of Oklahoma19
已完成
4 期
Lopinavir/Ritonavir (Kaletra) PK in ChildrenHIV/AIDS TreatmentHIV InfectionsNCT00810108Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)12